Literature DB >> 2337775

Angiotensin II inhibits acetylcholine release from human temporal cortex: implications for cognition.

J M Barnes1, N M Barnes, B Costall, Z P Horovitz, J W Ironside, R J Naylor, T J Williams.   

Abstract

Angiotensin II was shown to inhibit potassium-stimulated release of [3H]acetylcholine from slices of fresh human temporal cortex, obtained at surgery, and subsequently loaded with [3H]choline for the biochemical analyses. The inhibitory effect of angiotensin II was antagonised by the specific angiotensin II receptor antagonist [1-sarcosine, 8-threonine]-angiotensin II. High affinity binding sites were identified in the human temporal cortex using [125I]angiotensin II, and may provide the functional site of action of angiotensin II to modify [3H]acetylcholine release.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2337775     DOI: 10.1016/0006-8993(90)90294-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Angiotensin II-inhibition: effect on Alzheimer's pathology in the aged triple transgenic mouse.

Authors:  Linda Ferrington; Laura E Palmer; Seth Love; Karen J Horsburgh; Paul At Kelly; Patrick G Kehoe
Journal:  Am J Transl Res       Date:  2012-04-12       Impact factor: 4.060

2.  Angiotensin-converting enzyme inhibitors and incidence of mild cognitive impairment. The Italian Longitudinal Study on Aging.

Authors:  Vincenzo Solfrizzi; Emanuele Scafato; Vincenza Frisardi; Davide Seripa; Giancarlo Logroscino; Patrick G Kehoe; Bruno P Imbimbo; Marzia Baldereschi; Gaetano Crepaldi; Antonio Di Carlo; Lucia Galluzzo; Claudia Gandin; Domenico Inzitari; Stefania Maggi; Alberto Pilotto; Francesco Panza
Journal:  Age (Dordr)       Date:  2011-12-28

Review 3.  Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.

Authors:  Laure Rouch; Philippe Cestac; Olivier Hanon; Charlène Cool; Catherine Helmer; Béatrice Bouhanick; Bernard Chamontin; Jean-Franҫois Dartigues; Bruno Vellas; Sandrine Andrieu
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

Review 4.  Angiotensin converting enzyme inhibitors as potential cognitive enhancing agents.

Authors:  A M Domeney
Journal:  J Psychiatry Neurosci       Date:  1994-01       Impact factor: 6.186

5.  Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.

Authors:  Kaycee M Sink; Xiaoyan Leng; Jeff Williamson; Stephen B Kritchevsky; Kristine Yaffe; Lewis Kuller; Sevil Yasar; Hal Atkinson; Mike Robbins; Bruce Psaty; David C Goff
Journal:  Arch Intern Med       Date:  2009-07-13

6.  Central angiotensin II stimulation promotes β amyloid production in Sprague Dawley rats.

Authors:  Donglin Zhu; Jingping Shi; Yingdong Zhang; Bianrong Wang; Wei Liu; Zhicong Chen; Qiang Tong
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

7.  Association of Increased Serum ACE Activity with Logical Memory Ability in Type 2 Diabetic Patients with Mild Cognitive Impairment.

Authors:  Sai Tian; Jing Han; Rong Huang; Wenqing Xia; Jie Sun; Rongrong Cai; Xue Dong; Yanjue Shen; Shaohua Wang
Journal:  Front Behav Neurosci       Date:  2016-12-23       Impact factor: 3.558

8.  Administration of bovine casein-derived peptide prevents cognitive decline in Alzheimer disease model mice.

Authors:  Li-Juan Min; Yodai Kobayashi; Masaki Mogi; Kana Tsukuda; Akio Yamada; Koji Yamauchi; Fumiaki Abe; Jun Iwanami; Jin-Zhong Xiao; Masatsugu Horiuchi
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

Review 9.  AT1 Receptors: Their Actions from Hypertension to Cognitive Impairment.

Authors:  Hanxue Wu; Qi Sun; Shenglan Yuan; Jiawei Wang; Fanni Li; Hongli Gao; Xingjuan Chen; Rui Yang; Jiaxi Xu
Journal:  Cardiovasc Toxicol       Date:  2022-02-24       Impact factor: 2.755

Review 10.  Targeting Renin-Angiotensin System Against Alzheimer's Disease.

Authors:  Abadi Kahsu Gebre; Birhanetensay Masresha Altaye; Tesfay Mehari Atey; Kald Beshir Tuem; Derbew Fikadu Berhe
Journal:  Front Pharmacol       Date:  2018-04-30       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.